Hultcrantz M, Kleinman D, Vij R, Escalante F, Delforge M, Kotowsky N, Bitetti J, Boytsov N, Camadoo-O’Byrne L, Happ LP, Germain G, Urosevic A, Mahendran M, Duh MS, Laliberte F, Cavo M, Lee HC. Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States. Haematologica; https://doi.org/10.3324/haematol.2024.285893 [Early view].